Listed company MEI Pharma completes $100 million private placement, to be used for Litecoin strategic reserves
By: odaily.com|2025/07/23 02:11:52
Odaily News MEI Pharma announced the completion of a $100 million private placement financing, selling 29,239,767 shares of common stock or prepaid warrants of equivalent value at $3.42 per share. The proceeds will be used to establish a strategic reserve of Litecoin.
The company also appointed Charlie Lee, the founder of Litecoin and the lead investor in this private placement, to join the board of directors, and designated GSR as its digital asset and fund management consultant to oversee the execution of Litecoin reserve strategy. (Businesswire)
Bitcoin y las altcoins en una encrucijada: ¿nuevos máximos o corrección entrante?
WEEX causa sensación en BlockchainRIO 2025
También te puede interesar
Compartir
Ganadores
Últimas noticias sobre criptomonedas
10:28
Ethereum ICO Whale with 254,900 Tokens Nearing Liquidation, Deposited 23,000 ETH to CEX in the Past Week
10:25
The Central Bank of Russia has confirmed that it may relax cryptocurrency regulation rules.
10:22
OECD: Expects the Federal Reserve to "gradually" lower the key interest rate to 3.25% to 3.5%
10:20
Asset Management Giant Tidal Investments Acquires Approximately $60 Million in Strategy Stock
09:57
A certain whale with a significant BTC short position is planning to long at around $67,000, with the shorts currently showing a profit of $26.83 million.
Leer más
Comunitario
Atención al cliente:@weikecs
Cooperación empresarial:@weikecs
Trading cuantitativo y MM:[email protected]
Programa VIP:[email protected]